PACT - Public Activities Coordination Tool
PACT - Public Activities Coordination Tool
PACT - Public Activities Coordination Tool
The public activities coordination tool (PACT) provides an overview of the substance-specific activities that authorities are working on under REACH and the CLP Regulation. These activities are being carried out in line with ECHA’s Integrated Regulatory Strategy.
PACT provides up-to-date information on the activities planned, ongoing or completed by ECHA and/or MSCAs for a given substance in the following areas:
- Data generation and assessment – dossier evaluation, substance evaluation, informal hazard assessment (PBT/vPvB/ED).
- Assessment of regulatory needs (ARN).
- Regulatory risk management – harmonised classification and labelling (CLH) , SVHC identification, recommendations for inclusion in the Authorisation List, restriction.
A summary of all the substance-specific activities can be found under ‘Details’ for each entry.
Further information
- Understanding PACT
- Integrated Regulatory Strategy
- Substances of potential concern
- Dossier Evaluation status
- Substance evaluation
- Endocrine disruptor assessment
- PBT assessment
- Assessment of regulatory needs list
- Registry of CLH intentions until outcome
- Registry of SVHC intentions until outcome
- Recommendations for inclusion in the Authorisation list
- Registry of restriction intentions until outcome
Filter the list
The List does not contain any Substances.
| Data generation and assessment | ARN | Regulatory risk management | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| N-(3-aminopropyl)iminodiethanol | 225-642-0 | 4985-85-7 | - | - | 2 | - | 1 | - | - | - | - | Details |
| N-(4-aminophenyl)aniline | 202-951-9 | 101-54-2 | - | - | - | - | 1 | - | - | - | - | Details |
| N-(butoxymethyl)acrylamide | 217-442-7 | 1852-16-0 | - | - | - | - | 1 | - | - | - | - | Details |
| N-(C16-18, C18 unsatd alkyl)-N-methyl(C16-18, C18 unsatd alkyl)-1-amine | 806-914-3 | 1499182-59-0 | - | - | - | - | 1 | - | - | - | - | Details |
| N-(carboxymethyl)-3-[(2Z)-docos-2-enoylamino]-N,N-dimethylpropan-1-aminium | 447-060-8 | - | - | - | - | - | 1 | - | - | - | - | Details |
| N-(cyclopent-1-en-1-yl)morpholine | 213-316-0 | 936-52-7 | - | - | - | - | 1 | - | - | - | - | Details |
| N-(cyclopent-1-ene-1-yl)pyrrolidine | 230-463-6 | 7148-07-4 | - | - | - | - | 1 | - | - | - | - | Details |
| N-(hydroxymethyl)acrylamide | 213-103-2 | 924-42-5 | - | - | - | - | 1 | 1 | 1 | - | - | Details |
| N-(methoxymethyl)acrylamide | 222-871-8 | 3644-11-9 | - | - | 1 | - | 1 | - | - | - | - | Details |
| N-(tert-butyl)benzylamine | 222-179-6 | 3378-72-1 | - | - | - | - | 1 | - | - | - | - | Details |